33 results on '"Marhenke, Silke"'
Search Results
2. Genetic variation inTERTmodifies the risk of hepatocellular carcinoma in alcohol-related cirrhosis: results from a genome-wide case-control study
3. TNFR1 inhibition reduces lipogenesis and improves insulin resistance and fibrosis in NAFLD
4. Genetic variation in TERT modifies the risk of hepatocellular carcinoma in alcohol-related cirrhosis: results form a genome-wide case-control study
5. The Co‐mutational Spectrum Determines the Therapeutic Response in Murine FGFR2 Fusion‐Driven Cholangiocarcinoma
6. The TNFR1 Antagonist Atrosimab Is Therapeutic in Mouse Models of Acute and Chronic Inflammation
7. p53-Independent Induction of p21 Fails to Control Regeneration and Hepatocarcinogenesis in a Murine Liver Injury Model
8. Genetic Variation in HSD17B13 Reduces the Risk of Developing Cirrhosis and Hepatocellular Carcinoma in Alcohol Misusers
9. The PNPLA3 rs738409 GG genotype is associated with poorer prognosis in 239 patients with autoimmune hepatitis
10. TNF-Receptor-1 inhibition reduces liver steatosis, hepatocellular injury and fibrosis in NAFLD mice
11. Absence of Atg7 in the liver disturbed hepatic regeneration after liver injury
12. PS-177-HSD17B13 rs72613567 TA is associated with a reduced risk for developing hepatocellular carcinoma in patients with alcohol-related cirrhosis
13. FRI-044-PNPLA3 polymorphism is associated with disease progression in patients with autoimmune hepatitis
14. Treatment with metformin is associated with a prolonged survival in patients with hepatocellular carcinoma
15. Murine Liver Organoids as a Genetically Flexible System to Study Liver Cancer In Vivo and In Vitro
16. Genetic variants in PNPLA3 and TM6SF2 predispose to the development of hepatocellular carcinoma in individuals with alcohol-related cirrhosis
17. Heterozygous carriage of the alpha1-antitrypsin Pi*Z variant increases the risk to develop liver cirrhosis
18. Correction: Genetic Variants in PNPLA3 and TM6SF2 Predispose to the Development of Hepatocellular Carcinoma in Individuals With Alcohol-Related Cirrhosis
19. Safety and efficacy of chemosaturation in patients with primary and secondary liver tumors
20. Safety and efficacy of chemosaturation in patients with primary and secondary liver tumours: A single-centre experience after 54 treatments.
21. Dual Role of the Adaptive Immune System in Liver Injury and Hepatocellular Carcinoma Development
22. The BH3-only protein BID impairs the p38-mediated stress response and promotes hepatocarcinogenesis during chronic liver injury in mice
23. Smad7 regulates compensatory hepatocyte proliferation in damaged mouse liver and positively relates to better clinical outcome in human hepatocellular carcinoma
24. Chronic liver inflammation and hepatocellular carcinogenesis are independent of S100A9
25. p21 promotes sustained liver regeneration and hepatocarcinogenesis in chronic cholestatic liver injury
26. The degree of liver injury determines the role of p21 in liver regeneration and hepatocarcinogenesis in mice
27. Receptor for advanced glycation endproducts (RAGE) is a key regulator of oval cell activation and inflammation-associated liver carcinogenesis in mice
28. Activity of the mTOR inhibitor RAD001, the dual mTOR and PI3-kinase inhibitor BEZ235 and the PI3-kinase inhibitor BKM120 in hepatocellular carcinoma
29. Hepatocyte-specific S100a8 and S100a9 transgene expression in mice causes Cxcl1 induction and systemic neutrophil enrichment
30. Rapamycin delays tumor development in murine livers by inhibiting proliferation of hepatocytes with DNA damage
31. Activation of nuclear factor E2-related factor 2 in hereditary tyrosinemia type 1 and its role in survival and tumor development
32. Nuclear Factor-Eythroid 2–Related Factor 2 Prevents Alcohol-Induced Fulminant Liver Injury
33. 108 NRF2 Prevents Alcohol Induced Fulminant Liver Injury
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.